| Lancaster Health Services | |
| 1350 S Madison St, Lancaster, Wisconsin 53813 | |
| (608) 723-4143 | |
| Name | Lancaster Health Services |
|---|---|
| Location | 1350 S Madison St, Lancaster, Wisconsin |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 50 |
| Occupancy Rate | 65.2% |
| Medicare ID (CCN) | 525352 |
| Legal Business Name | Nsh Lancaster Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1508409434 |
| Organization Name | NSH LANCASTER LLC |
| Address | 1350 S Madison St, Lancaster, WI 53813 |
| Phone Number | 608-723-4143 |
News Archive
In Iowa, the Republican presidential contenders tried to outdo one another in attacking reproductive rights as they sought the support of caucusgoers from the religious right. In New Hampshire, where voters are less socially conservative, the candidates have focused more on economic issues.
A partnership between Indiana University School of Medicine and the Regenstrief Institute is one of 11 U.S. recipients selected to train researchers to conduct patient-centered outcomes research within learning health systems.
ProtAffin AG, a biotechnology company developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures, today announced it has signed a manufacturing contract with CMC Biologics' Danish operations, located in Copenhagen, Denmark for manufacture of its lead product PA401 for the treatment of chronic obstructive pulmonary disease (COPD). The contract will cover manufacture and supply of PA401 for preclinical development and early clinical development in COPD and related respiratory indications.
Golimumab, a new tumour necrosis factor-α (TNF-α) inhibitor reduces the signs and symptoms of rheumatoid arthritis in patients who have previously received any other TNF-α inhibitor, and might be a good option for patients who have inadequate responses to one or two other TNF-α inhibitors, finds an Article published Online first and in this week's edition of The Lancet.
Donald W. Fisher, PhD, CAE President and CEO of the American Medical Group Association (AMGA), today announced its policy stance on the pending Congressional action to address the Medicare sustainable growth rate formula (SGR) problem for physicians.
› Verified 7 days ago
| NPI Number | 1619960846 |
| Organization Name | LANCASTER CARE CENTER LLC |
| Doing Business As | ATRIUM POST ACUTE CAREOF LANCASTER |
| Address | 1350 S Madison St, Lancaster, WI 53813 |
| Phone Number | 608-723-4143 |
News Archive
In Iowa, the Republican presidential contenders tried to outdo one another in attacking reproductive rights as they sought the support of caucusgoers from the religious right. In New Hampshire, where voters are less socially conservative, the candidates have focused more on economic issues.
A partnership between Indiana University School of Medicine and the Regenstrief Institute is one of 11 U.S. recipients selected to train researchers to conduct patient-centered outcomes research within learning health systems.
ProtAffin AG, a biotechnology company developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures, today announced it has signed a manufacturing contract with CMC Biologics' Danish operations, located in Copenhagen, Denmark for manufacture of its lead product PA401 for the treatment of chronic obstructive pulmonary disease (COPD). The contract will cover manufacture and supply of PA401 for preclinical development and early clinical development in COPD and related respiratory indications.
Golimumab, a new tumour necrosis factor-α (TNF-α) inhibitor reduces the signs and symptoms of rheumatoid arthritis in patients who have previously received any other TNF-α inhibitor, and might be a good option for patients who have inadequate responses to one or two other TNF-α inhibitors, finds an Article published Online first and in this week's edition of The Lancet.
Donald W. Fisher, PhD, CAE President and CEO of the American Medical Group Association (AMGA), today announced its policy stance on the pending Congressional action to address the Medicare sustainable growth rate formula (SGR) problem for physicians.
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
In Iowa, the Republican presidential contenders tried to outdo one another in attacking reproductive rights as they sought the support of caucusgoers from the religious right. In New Hampshire, where voters are less socially conservative, the candidates have focused more on economic issues.
A partnership between Indiana University School of Medicine and the Regenstrief Institute is one of 11 U.S. recipients selected to train researchers to conduct patient-centered outcomes research within learning health systems.
ProtAffin AG, a biotechnology company developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures, today announced it has signed a manufacturing contract with CMC Biologics' Danish operations, located in Copenhagen, Denmark for manufacture of its lead product PA401 for the treatment of chronic obstructive pulmonary disease (COPD). The contract will cover manufacture and supply of PA401 for preclinical development and early clinical development in COPD and related respiratory indications.
Golimumab, a new tumour necrosis factor-α (TNF-α) inhibitor reduces the signs and symptoms of rheumatoid arthritis in patients who have previously received any other TNF-α inhibitor, and might be a good option for patients who have inadequate responses to one or two other TNF-α inhibitors, finds an Article published Online first and in this week's edition of The Lancet.
Donald W. Fisher, PhD, CAE President and CEO of the American Medical Group Association (AMGA), today announced its policy stance on the pending Congressional action to address the Medicare sustainable growth rate formula (SGR) problem for physicians.
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 18.58 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 5.31 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 31.82 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.15 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 2.36 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0.77 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0.77 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 21.31 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 97.96 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 21.9 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 21.55 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 2.5 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 77.79 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 93.64 | 82.93 |
News Archive
In Iowa, the Republican presidential contenders tried to outdo one another in attacking reproductive rights as they sought the support of caucusgoers from the religious right. In New Hampshire, where voters are less socially conservative, the candidates have focused more on economic issues.
A partnership between Indiana University School of Medicine and the Regenstrief Institute is one of 11 U.S. recipients selected to train researchers to conduct patient-centered outcomes research within learning health systems.
ProtAffin AG, a biotechnology company developing a novel class of biopharmaceutical products that act by targeting cell-surface glycan structures, today announced it has signed a manufacturing contract with CMC Biologics' Danish operations, located in Copenhagen, Denmark for manufacture of its lead product PA401 for the treatment of chronic obstructive pulmonary disease (COPD). The contract will cover manufacture and supply of PA401 for preclinical development and early clinical development in COPD and related respiratory indications.
Golimumab, a new tumour necrosis factor-α (TNF-α) inhibitor reduces the signs and symptoms of rheumatoid arthritis in patients who have previously received any other TNF-α inhibitor, and might be a good option for patients who have inadequate responses to one or two other TNF-α inhibitors, finds an Article published Online first and in this week's edition of The Lancet.
Donald W. Fisher, PhD, CAE President and CEO of the American Medical Group Association (AMGA), today announced its policy stance on the pending Congressional action to address the Medicare sustainable growth rate formula (SGR) problem for physicians.
› Verified 7 days ago
Lancaster Health Services Location: 1350 S Madison St, Lancaster, Wisconsin 53813 Phone: (608) 723-4143 |